论文部分内容阅读
Multidimensional Boundary Crossing Problems with Applications
【机 构】
：
National Central University,Taiwan
【出 处】
：
上海交通大学
【发表日期】
：
2016年4期
其他文献
Semidefinite Programs(SDPs)have provably good properties for community detection.We give a new SDP formulation to handle other types of blockmodel structure,such as hierarchical classes,latent space m
Interim Evaluation of Efficacy or Futility in Group-sequential Clinical Trials With Multiple Co-prim
We discuss group-sequential designs in superiority clinical trials with multiple co-primary endpoints,i.e.,when trials are designed to evaluate if the test intervention is superior to the control on a
Clinical,pharmaceutical,and genetic association studies usually require patients with a specific disease to be identified.Hospitals with electronic medical record(EMR)systems,especially the large and
The accurate determination of control limits is crucial in statistical process control.The usual approach consists in computing the limits so that the in-control run-length distribution has some desir
An Empirical Bayes Method for Genotyping and SNP Detection Using Multi-sample Next-generation Sequen
The development of next generation sequencing technology provides an efficient and powerful approach to rare variant detection.To identify genetic variations,the essential question is how to quantity
Skewed data are common in sample surveys.In probability-proportional-to-size sampling,we proposed a Bayesian predictive method for estimating finite population quantiles.We assumed the survey outcome
During a normal menstrual cycle,the basal body temperature(BBT)rises around the day of the ovulation.The shift is small; it can be abrupt or gradual and it typically persists almost up to the end of t
When decision-making involves pre-determined paths,more important than any power consideration,it is imperative for multiple tests to respect such paths.This presentation shows how the partitioning pr
The high failure rate in Phase Ⅲ clinical trials has raised more and more attention on opti-mizing the drug development design as well as a better utilization of data from early trial/study.One of the